Understanding Coarse Dispersions in Pharmaceutical Suspensions

In the pharmaceutical industry, suspensions are a vital form of dosage that involves the dispersion of solid particles within a liquid medium. Understanding the mechanics behind coarse dispersions is essential for ensuring the efficacy and stability of these formulations.

Defining Coarse Dispersions

A pharmaceutical suspension consists of an internal phase, which is the active therapeutic ingredient, uniformly distributed throughout an external phase, typically a liquid. The solid particles within the suspension generally range from 0.5 to 5 microns in size. These particles are maintained in suspension with the help of one or more suspending agents, which can be natural or synthetic. The external phase is usually aqueous, although organic or oily liquids may be used for non-oral applications.

Interfacial Properties of Suspended Particles

The stability of a suspension hinges on the interfacial properties of the suspended particles. When solid particles are reduced to smaller sizes, their increased surface area leads to a higher surface free energy, making the system thermodynamically unstable. This instability causes particles to aggregate, as they seek to reduce the total surface area and, consequently, the free energy. In a liquid suspension, particles may flocculate, forming aggregates held together by weak van der Waals forces. Under specific conditions, such as in baked products, stronger interactions can lead to the formation of aggregates.

The work done to divide solids into smaller particles and increase the total surface area can be expressed mathematically. The change in free energy (ΔG) associated with this process is given by the equation ΔG = γSLΔA, where γSL represents the interfacial tension between the liquid medium and the solid particles. Equilibrium is achieved when ΔG equals zero, which can be approached by reducing interfacial tension or decreasing the area of contact between particles. This reduction can be facilitated by surfactants, although it cannot typically be reduced to zero.

Settling Behaviour in Suspensions

In a suspension, when sedimentation occurs, the particles arrange themselves closely, with smaller particles filling the spaces between larger ones. The weight of the particles above compresses those below, eventually overcoming the energy barrier that keeps the particles apart. This dense arrangement can lead to a hard cake formation, which is difficult to resuspend. To re-disperse these sedimented particles, it is necessary to overcome the energy barrier that has formed.

When flocculated, particles still face a significant energy barrier that prevents them from easily coming into contact with one another. The distance of separation required for weak flocculation to occur typically ranges from 1000 to 2000 Å. This distance allows for the formation of loosely structured flocs that can be readily re-dispersed with gentle agitation.

Desirable Characteristics of Suspensions

For a pharmaceutical suspension to be effective, it must exhibit several desirable features:

• The suspension should remain homogeneous for a reasonable duration between shaking.
• Any sediment formed during storage should be easily redisperable with gentle shaking.
• The particle size of the suspended drug should remain consistent over time, avoiding any significant crystal growth.
• The viscosity of the suspension should not be excessively high, allowing for easy pouring from its container.

Examples of Pharmaceutical Suspensions

Various formulations exist within the category of pharmaceutical suspensions, including:

• Antacid oral suspensions
• Antibacterial oral suspensions
• Dry powders for oral suspensions (e.g., antibiotics)
• Analgesic oral suspensions
• Anthelminthic oral suspensions
• Anticonvulsant oral suspensions
• Antifungal oral suspensions

Classification of Suspensions

Suspensions can be classified based on various criteria:

By General Class

• Oral suspensions (e.g., Paracetamol suspension)
• Externally applied suspensions (e.g., Calamine lotion)
• Parenteral suspensions (e.g., Insulin zinc suspension)

By Proportion of Solid Particles

• Dilute suspensions (2 to 10% w/v solid, e.g., cortisone acetate, prednisolone acetate)
• Concentrated suspensions (50% w/v solid, e.g., zinc oxide suspension)

Coarse suspensions are defined as those containing particles larger than approximately 1 micron, whereas colloidal suspensions have particles smaller than about 1 micron. Nanosuspensions consist of drug particles stabilized by surfactants that are nanosized (10 nanograms) and less than 1 mm in diameter.

Conclusion

Understanding the properties and behaviours of coarse dispersions in pharmaceutical suspensions is crucial for developing stable and effective formulations. By carefully considering interfacial properties, settling behaviour, and the desired characteristics of suspensions, pharmaceutical professionals can enhance the quality and efficacy of their products.